שווי כולל של החברה: Revelation Biosciences Corp (REVB)

Revelation Biosciences (REVB) is a biotech startup developing immunity correction methods whose financial stability depends on clinical trial outcomes. Efficient supply chain management and raw material temperature control help maintain high profitability. However, funding shortages and R&D expenses force the company to raise capital through secondary offerings. The market dynamics reflected in the quotes show an Enterprise Value of -8.62.

The Revelation Biosciences (REVB) model relies on long-term market monopolization through immunostimulant patents that create a stable cash flow. By analyzing the historical enterprise value trend, an investor can identify the business's actual price tag, calculated as the sum of market capitalization and net debt, which allows for an assessment of the current acquisition cost considering the company's liquidity.